Four-peptide research blend
KLOW
GHK-Cu / KPV / BPC-157 / thymosin beta-4 blend
Variable formula / not FDA-approvedAn 80 mg research blend labeled as GHK-Cu 50 mg, KPV 10 mg, BPC-157 10 mg, and thymosin beta-4 10 mg. KLOW is a product formula, not one molecule or a clinically standardized medicine.
FULL RESEARCH GRAPHIC
KLOW research overview
A dedicated overview of the labeled four-peptide formula, evidence boundaries, and the 80 mg total blend.
Tap the graphic to open the full-resolution version.
RESEARCH SIGNAL MAP
04 ACTIVE FIELDSEVIDENCE READOUT
Variable formula / not FDA-approvedEach ingredient has a different evidence base, and combining them does not prove additive benefit, compatibility, stability, or safety. Claims about the blend must not be inferred from research on one component.
BOUNDARY CHECK
CONTEXT REQUIREDThe report on file identifies all four components and measures content and chromatographic purity, but it does not report sterility, endotoxins, clinical effectiveness, or a validated human-use protocol.
SUBMITTED LAB DOCUMENTS
Test results
Reports may describe other strengths or blends. Match the labeled amount, composition, and exact lot to your vial. A report for another strength does not verify your vial. Each record identifies whether an exact lot was supplied.
VIAL REFERENCE
3 mL mixing math & dosing context
Every number is labeled by evidence level. The 3 mL reference calculates concentration and U-100 volume; it does not prove solvent compatibility, sterility, stability, or suitability for injection.
KLOW 80 mg total blend
Label formula: GHK-Cu 50 mg + KPV 10 mg + BPC-157 10 mg + thymosin beta-4 10 mg. The calculator uses the labeled 80 mg formula, not the assayed content.
Change the liquid. See the amount.
Calculation only: vial amount ÷ liquid volume × draw volume. It does not determine what dose to use or confirm product compatibility.
3.0 mL BAC-water workflow
- First confirm that bacteriostatic water and a 3.0 mL final volume are compatible with the exact product and vial capacity.
- Clean both vial stoppers with alcohol and allow them to dry.
- Add the 3.0 mL slowly down the inside wall instead of directing pressure onto the powder.
- Gently roll or swirl until dissolved; do not shake.
- Use product-specific refrigeration and discard guidance. If none exists, do not invent a beyond-use date.
No controlled human dose for KLOW
No controlled human trial establishes a dose, frequency, route, cycle length, or combined protocol for this four-component formula. The calculator shows proportional vial math only.
FDA — compounding safety risks ↗U-100 means 100 units = 1.0 mL. Any table result above 100 units exceeds one standard 1 mL U-100 syringe.